Drawing for FLUOSPHERA

USPTO serial 79361288

FLUOSPHERA

Reviewed by CopyMark Law Group

Status 645Office Action
Filing date
Status date
Registration date
Examiner
GILLANI, MAHREEN A
Law office
TMEG LAW OFFICE 109

What this means

The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.

Status 645: Status 645 means the USPTO mailed a final refusal maintaining at least one objection to your application. You can respond, appeal to the Trademark Trial and Appeal Board, or allow the application to abandon.

Need help with FLUOSPHERA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical and veterinary products for the treatment of liver diseases and disorders, endocrinological diseases and disorders, cardiovascular diseases and disorders, and cancer; diagnostic products for medical use, namely, medical diagnostic reagents and assays for testing of body fluids, medical diagnostic reagents, diagnostic preparations for medical use; pharmaceutical healthcare preparations for the treatment of liver diseases and disorders, endocrinological diseases and disorders, cardiovascular diseases and disorders, and cancer; medicinal preparations and substances for the treatment of liver diseases and disorders, endocrinological diseases and disorders, cardiovascular diseases and disorders, and cancer; biochemical preparations for medical or veterinary use for the treatment of liver diseases and disorders, endocrinological diseases and disorders, cardiovascular diseases and disorders, and cancer; biological and chemical reagents for medical or veterinary use; biological and chemical preparations for medical use for the treatment of liver diseases and disorders, endocrinological diseases and disorders, cardiovascular diseases and disorders, and cancer; biotechnological preparations for medical use, namely, for the treatment of liver diseases and disorders, endocrinological diseases and disorders, cardiovascular diseases and disorders, and cancer; biotechnological products for medical use, namely, medical preparations for the treatment of liver diseases and disorders, endocrinological diseases and disorders, cardiovascular diseases and disorders, and cancer; biological tissue cultures other than for medical or veterinary use; none of the foregoing relating to latex microspheresACTIVE
042Technological services, namely, research and design for medical, biomedical and genetic purposes in the pharmaceutical field; technological services, namely, industrial analysis and research in the field of biotechnology; medical research and development in the pharmaceutical field; research and development in the field of biotechnology; research in the fields of biology; research in the field of biochemistry; development and evaluation of pharmaceutical products; testing of pharmaceutical products; research and development of new products; pharmaceutical research and development services; providing information and data relating to technological research and development in the field of biotechnology; providing research information and results in the field of biotechnology and medicine from an online searchable database; pharmaceutical drug development services; pharmaceutical research and development; development and research of new products for third parties in the fields of pharmaceuticals and biotechnology; research laboratory analysis services in the fields of biotechnology, pharmacotherapy, and pharmaceutical research and development; pharmaceutical and biological development and research services for third parties; evaluation of pharmaceutical product development; laboratory research in the field of medicinal and analytical chemistry, biology, pharmacology and toxicology; none of the foregoing relating to latex microspheresACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 13, 2026GNFNNOTIFICATION OF FINAL REFUSAL EMAILED
Jul 13, 2026GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jul 13, 2026CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
May 18, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED
May 18, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
May 18, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 17, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 17, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 17, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 29, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Sep 29, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 29, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 29, 2025NREVNOTICE OF REVIVAL - E-MAILED
Sep 29, 2025PETGPETITION TO REVIVE-GRANTED
Sep 29, 2025PROATEAS PETITION TO REVIVE RECEIVED
Jul 29, 2025MAB2ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jul 29, 2025ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jan 14, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 14, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 14, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 16, 2024RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Nov 17, 2024OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Oct 29, 2024OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 15, 2024GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jan 15, 2024GNSLLETTER OF SUSPENSION E-MAILED
Jan 15, 2024CNSLSUSPENSION LETTER WRITTEN
Dec 7, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Dec 6, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 6, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 26, 2023RFNTREFUSAL PROCESSED BY IB
Jun 6, 2023RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jun 6, 2023ATRVATTORNEY REVIEW COMPLETED
Jun 6, 2023ATRVATTORNEY REVIEW COMPLETED
Jun 6, 2023CREVCORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED
Jun 6, 2023RFRRREFUSAL PROCESSED BY MPU
Jun 5, 2023CRCVCORRECTION TRANSACTION RECEIVED FROM IB
Apr 8, 2023RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 7, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 26, 2023DOCKASSIGNED TO EXAMINER
Feb 7, 2023MAFRAPPLICATION FILING RECEIPT MAILED
Feb 3, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 2, 2023REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance